Literature DB >> 8557399

Multicentre study for diagnostic evaluation of an assay for simultaneous detection of antibodies to HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0).

P Bachmann1, J Beyer, S Brust, W Engelhardt, L G Gürtler, K O Habermehl, A Karakassopoulos, U Michl, A Mühlbacher, M Stöffler-Meilicke.   

Abstract

The aim of the study was to evaluate a new ELISA for detection of HIV-1, HIV-2 and HIV-1 subtype 0 (HIV-0) antibodies. The assay format is based on the antigen sandwich principle. To enable specific detection of HIV-0 antibodies, in addition to HIV-1 and HIV-2 antigens HIV-0 antigen is used for coating the solid phase and for the conjugate. The results show that all 12 HIV-0 samples tested were detected with a high degree of reactivity, as were all the 1,144 anti-HIV-1 and 424 anti-HIV-2 positive samples. The capacity of the test to enable early detection of seroconversions is equivalent to that of other sandwich ELISAs. The specificity of the assay was determined to be 99.89/99.94% (initial/after retest) using 58,366 samples, which is superior to the other ELISAs used for comparison. Even with difficult samples (i.e. samples of African origin, samples known to cause false-positive reactivity in different ELISAs, or samples containing potential interference factors) there were very few false-positive reactions. Therefore, the new assay is well suited for screening blood donations as well as for evaluating samples from patients of different geographic origin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557399     DOI: 10.1007/bf01716301

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

1.  Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots.

Authors:  L G Gürtler; L Zekeng; F Simon; J Eberle; J M Tsague; L Kaptue; S Brust; S Knapp
Journal:  J Virol Methods       Date:  1995-02       Impact factor: 2.014

2.  Prevalence of HIV-1 subtype O infection in Cameroon: preliminary results.

Authors:  L Zekeng; L Gurtler; E Afane Ze; A Sam-Abbenyi; G Mbouni-Essomba; E Mpoudi-Ngolle; M Monny-Lobe; J B Tapka; L Kaptue
Journal:  AIDS       Date:  1994-11       Impact factor: 4.177

3.  Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infections.

Authors:  C Schable; L Zekeng; C P Pau; D Hu; L Kaptue; L Gurtler; T Dondero; J M Tsague; G Schochetman; H Jaffe
Journal:  Lancet       Date:  1994-11-12       Impact factor: 79.321

4.  A new human retrovirus isolate of West African origin (SBL-6669) and its relationship to HTLV-IV, LAV-II, and HTLV-IIIB.

Authors:  J Albert; U Bredberg; F Chiodi; B Böttiger; E M Fenyö; E Norrby; G Biberfeld
Journal:  AIDS Res Hum Retroviruses       Date:  1987       Impact factor: 2.205

5.  Laboratory and epidemiologic evaluation of an enzyme immunoassay for antibodies to HTLV-III.

Authors:  J W Ward; A J Grindon; P M Feorino; C Schable; M Parvin; J R Allen
Journal:  JAMA       Date:  1986-07-18       Impact factor: 56.272

6.  A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon.

Authors:  L G Gürtler; P H Hauser; J Eberle; A von Brunn; S Knapp; L Zekeng; J M Tsague; L Kaptue
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody.

Authors:  J L Gallarda; D R Henrard; D Liu; S Harrington; S L Stramer; J E Valinsky; P Wu
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

8.  Serologic testing for human immunodeficiency virus antibodies.

Authors:  J M Steckelberg; F R Cockerill
Journal:  Mayo Clin Proc       Date:  1988-04       Impact factor: 7.616

9.  Detection of human immunodeficiency virus type 1 antibody by using commercially available whole-cell viral lysate, synthetic peptide, and recombinant protein enzyme immunoassay systems.

Authors:  J E Johnson
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

10.  Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin.

Authors:  R De Leys; B Vanderborght; M Vanden Haesevelde; L Heyndrickx; A van Geel; C Wauters; R Bernaerts; E Saman; P Nijs; B Willems
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.